These Are the Drugs and Vaccines That Might End the Coronavirus Pandemic

STEPH DAVIDSON/GETTY

COVID-19 (an acronym for Coronavirus Disease 2019), also known as Coronavirus Disease, incorrectly, as Coronavirus Pneumonia, is an infectious disease caused by the SARS-CoV-2 virus. It was first detected in the Chinese city of Wuhan in December 2019. Having reached more than 100 territories, the World Health Organization declared it a pandemic on March 11, 2020.

Now, it is necessary to talk about possible solutions to attack COVID-19 and possibly end it. Notably, almost all clinical trials are in the early stages, and it could take weeks or months to get answers about what works.

Certainly more than 200 different programs have been launched to develop vaccines and therapies to combat the Covid-19 pandemic. From well-known industry giants like Gilead Sciences Inc. to Johnson & Johnson, they participate in a worldwide race to find and test products. With a more than likely vaccine out of reach for this year, the short-term hope for a means to stifle the global spread of the new coronavirus is based on finding an antiviral treatment that can improve the odds of survival for those affected. with Covid-19.

Alternatives that could end COVID-19

It should be noted that with more than 70 vaccines in development and at least the largest number of drugs under review, not all experimental therapies or vaccines are included here. Furthermore, almost all of these programs are in the early stages, which means that the gold standard for data is still difficult to achieve.

Antivirals

• Drug: Remdesivir; from Gilead Sciences.

• Drug Hydroxychloroquine, chloroquine; from the company Generic drugs made by Teva Pharmaceutical Industries Ltd., Sanofi, Mylan NV, Natco Pharma Ltd., Novartis AG, Bayer AG and others.

• Drug: Favipiravir; Zhejiang Hisun Pharmaceutical Co.

Vaccines

• Drug: mRNA-1273; of the company Moderna Inc.

• Drug: INO-4800; from the company Inovio Pharmaceuticals Inc.

• Drug: BNT162; from BioNTech SE, Pfizer Inc.

Indirect Therapies

• Drug: Kevzara; of the company Regeneron Pharmaceuticals Inc. and Sanofi

• Drug: Actemra, alone or in combination with the flu drug Avigan; Roche Holding AG, Chugai Pharmaceutical Co.

• Drug: Jakafi; from Incyte Corp., Novartis AG.

Read more.

Source: Cristin Flanagan, Riley Griffin, Robert Langreth | Bloomberg